D
Tierney, Lawrence M., McPhee, Stephen J., Papadakis, Maxine A.
Current Medical Diagnosis & Treatment, 45th Edition
document.getElementById('working').innerHTML = ''; function hide_scrollbar() { var e = document.body; e.style.scrollbarBaseColor = '#fff'; e.style.scrollbarArrowColor = '#fff'; e.style.scrollbarDarkShadowColor = '#fff'; e.style.scrollbarShadowColor = '#fff'; } function show_scrollbar() { var e = document.body; e.style.scrollbarBaseColor = '#ccc'; e.style.scrollbarArrowColor = '#000'; e.style.scrollbarDarkShadowColor = '#000'; e.style.scrollbarShadowColor = '#666'; } function toggle_CA(e) { var src; src = window.parent.getSrc(e); if (src.nextSibling.style.display == 'block') { src.nextSibling.style.display='none'; src.innerHTML='View Answer'; } else { src.nextSibling.style.display='block'; src.innerHTML='Hide Answer'; } } function resolve_link(e,setid,locator,dbid,toan) { e.href = "ovidweb.cgi?S=IDNJHKKKJGEPJK00D;FTS+Link+Set+Ref=" + setid + "|" + locator + "|" + dbid + "|" + toan; return true; }
H
H1 receptor blocking drugs See Antihistamines
H2 receptor blocking drugs 588–589
for dyspepsia 537
gastrin levels affected by 595
for gastroesophageal reflux disease 568
for NSAID gastritis 583
nutrients affected by 1260
for peptic ulcer disease 588–589 589 590 590
for stress gastritis 583
H63D mutation See also HFE gene
in hemochromatosis 676 677
H1069Q mutation, in Wilson's disease 678
H pylori infection See Helicobacter pylori infection
HAART regimens See Highly active antiretroviral therapy
Habitrol See Nicotine, for replacement therapy in smoking cessation
Habitual (recurrent) abortion 769
HACEK organisms, endocarditis caused by 1415 1419
Haemophilus 1422 1552 1553
aphrophilus, endocarditis caused by 1415
ducreyi 1433
influenzae 1422
immunization against 1305–1306
pneumonia caused by 248 251 254 1422 1553
in HIV infection/AIDS 1323 1422
parainfluenzae, endocarditis caused by 1415
Hair
excess of See Hirsutism
exclamation, in alopecia areata 144
loss of 144–145
drugs causing 145 148
Hair analysis, for drug detection 1083
Hair cells
chemical destruction of for vertigo 193
hearing loss caused by loss of 180
Hairy cell leukemia 511–512 1663
aplastic anemia differentiated from 497
rheumatic manifestations of 863
Hairy leukoplakia, in HIV infection/AIDS 216 217 1325
Halcion See Triazolam
Haldol See Haloperidol
Hallucinations/hallucinosis
alcoholic (organic) 1084 1085–1086 1092
in delirium 1092
intracranial mass lesions causing 1001
in Lewy body dementia 56
luminous, in migraine headache 975
in narcolepsy 1080
in schizophrenia/psychotic disorders 1058
substance-induced 1092
Hallucinogenic mushroom poisoning 1627 1629 1630
Hallucinogens 1627
Hallucinosis See Hallucinations/hallucinosis
Halobetasol 88
Halofantrine 1490 1494 1496 1497
resistance to 1492
Haloperidol 1059 1060 1060
adverse ocular effects of 178
for aggressive/violent behavior 1082 1093
for alcoholic hallucinosis 1086
antidepressant drug interactions and 1074
decanoate form of 1062
for delirium 59 1093
intravenous 1062
overdose/toxicity of 1060 1633
for Tourette's syndrome 1014
HAM See Human T cell lymphotropic/leukemia virus (HTLV), myelopathy of
Hamartomatous polyposis syndromes 636
Hamburger See Beef
Hamman-Rich syndrome (acute interstitial pneumonitis/AIP) 277
HAMP gene, in juvenile-onset hemochromatosis 676
Hampton's hump, in pulmonary embolism 281–282
Hand
burn injuries of, maintenance of function and 1598
in complex regional pain syndrome (reflex sympathetic dystrophy) 822
in immersion syndrome 1592
in Raynaud's disease/phenomenon 464 465
Hand dermatitis, vesiculobullous (pompholyx/dyshidrosis/dyshidrotic eczema) 111–112
Hand disinfection/washing, in infection control 1291 1292
Hand-foot-mouth disease
coxsackieviruses causing 204 1390
enterovirus 71 causing 1390–1391
herpetic stomatitis differentiated from 204
Hand movements (visual acuity) 151
Handgrip, heart murmurs affected by 329
P.1803
Hantaviruses/Hantaan virus 1378
hantavirus pulmonary syndrome caused by 1378
hemorrhagic fever caused by 1376
Haptoglobin
in hemolytic anemia 490
laboratory reference range for 1739
Harris-Benedict equation 1253 1281
Hartley-Dunhill operation 1140
Hashimoto's (chronic lymphocytic) thyroiditis 1136 1141 1143–1144 1146
HLA in 801
solitary thyroid nodule in 1120
thyroid antibodies in 1118 1143 1145
Hashish 1088
Hashitoxicosis 1146
HAV See Hepatitis A virus
Havrix See Hepatitis A vaccine
Hay fever See Allergic rhinitis
Hb See Hemoglobin
HbA1 See Hemoglobin A1/A1a/A1b/A1c
HbA2 See Hemoglobin A2
HBcAg 653
antibody to (anti-HBc) 653 654 654
screening blood for 534
HbCO See Carboxyhemoglobin levels
HBeAg 653 654 654 659
antibody to (anti-HBe) 653 654 654 659
HbF See Hemoglobin F
HBIG See Hepatitis B immune globulin
HBsAg 653 653 654
antibody to (anti-HBs) 653 653 654
in hepatocellular carcinoma 682
maternal carrier state/transmission to newborn and 653
vaccination recommendations and 657 764
screening blood for 534
HBV See Hepatitis B virus
hCG See Human chorionic gonadotropin
HCO3- See Bicarbonate
Hct See Hematocrit
HCTZ See Hydrochlorothiazide
HCV See Hepatitis C virus
HDCV (human diploid cell) rabies vaccine 1314 1370–1371
HDL See High-density lipoproteins
HDV See Hepatitis D virus
Head injury 1019–1020 1020
headache associated with 977
hearing loss associated with 187 188
hypopituitarism and 1104
seizures associated with 980
vertigo associated with 191
Head lice 135
Head and neck cancer
chemotherapy of 1664
lymphoma 216
metastatic 216
smoking and 5 1646 1647
Head and neck surgery, antibiotic prophylaxis for 47
Head-up tilt table testing, in syncope evaluation 368 384
Headache 31–33 32 974–978
acupuncture for 1726 1728
acute 31–33 32
in acute mountain sickness 1604
cerebral arteriovenous malformations causing 997
in giant cell arteritis 846 977
hypertension and 32 425
in intracerebral/subarachnoid hemorrhage 32 978 995
from intracranial aneurysm leak 996
ocular disorders and 32 150
oral contraceptive use and 753
in pheochromocytoma 32 1174
in primary angiitis of central nervous system 851
in pseudotumor cerebri 1005
Health care providers See also Physician
HIV transmission risk and 1319 1333
relationship of with patient See Doctor–patient relationship
SARS transmission prevention and 1386
tuberculosis vaccination for 263
Health care proxy See Advance directives
Health maintenance/disease prevention 2–19 3
in elderly 54–55
Hearing, evaluation of 180–181
in elderly 51 52
Hearing aids/hearing amplification 181
compliance with use of 52
in recruitment 189–190
Hearing loss 180–181
aminoglycosides causing 1573
auditory tube dysfunction causing 180 183
autoimmune 189
conductive 180
confusion/dementia and 57
in elderly (presbyacusis) 51 52 180 187–188
in endolymphatic hydrops (Meniere's syndrome) 191
glomus tumors causing 187
head trauma causing 187 188
hereditary 188–189
in HIV infection/AIDS 194
in labyrinthitis 191
neural 180
eighth nerve lesions causing 180
noise trauma causing 180 181 187 188
ossicular chain disruption causing 180
in otitis media 185
in otosclerosis 180 186
ototoxicity and 188
physical trauma causing 187 188
sensorineural 180
sensory 180 187–189
sudden 188
tinnitus and 189
vertigo and 190
vestibular schwannoma (acoustic neurinoma) causing 180 193 1000
Hearing rehabilitation 181
Heart 312–418
examination of
in cardiac failure 389
in cardiovascular screening of athletes 418
in myocardial infarction 356
holiday 375
in hypertension 426
myxedema 1132 1133
Starling's law of 386
systemic diseases affecting 413–414
traumatic injury of 414
Heart block See Atrioventricular (heart) block
Heart disease 312–418
anthracycline use and 1685
appearance of patients with 313–314
in athletes, screening for 417–418
carcinoid 413–414 611
cardiomyopathies 400–405 401
in hyperthyroidism 1137 1142
peripartum 417 778
in Chagas' disease 399 1465 1466 1467
chest pain in 312
Chlamydia pneumoniae in 446 1442
cholesterol/lipoproteins in 339 340
screening tests for levels of 1244–1247 1245–1246
coenzyme Q10 for 1721 1722
conduction disturbances 382–385
congenital 318–325
pregnancy and 416 777–778
coronary (arteriosclerotic/ischemic) 339–366
in diabetes mellitus 1225
diagnosis of 316–318
dyspnea in 23–24 312–313
endocarditis prophylaxis and 1416 1416 1417
estrogen replacement therapy and 341 761 1187 1188
functional classification of 313
pregnancy and 778 778
homocysteine/hyperhomocysteinemia in 10–11 341 1706–1707
hypertension and 314 424–425
hyperthyroidism and 389 1132 1137 1141–1142
hypertriglyceridemia and 1252
in hypothyroidism 1132
in Lyme disease 408 1458 1461 1461
in Marfan's syndrome 414 1707 1708
metabolic syndrome (syndrome X/CHAOS) and 339
myocarditis 398–400 399
neoplastic 413
pericardial disorders and 407–410
pleural effusion in 297
cardiac failure and 300 390
in polyarteritis nodosa 845
pregnancy and 416–417 777–778 778
preoperative evaluation/management of patient with 36–41 36 37 38 39 415
prevention of 5–12 340–342
antihypertensive therapy in 11–12
aspirin in 341
exercise/activity and 12 341
hyperhomocysteinemia prevention and 10–11 341 1707
lipid disorder prevention/management and 8–10 341
cholesterol screening and 1244–1247 1245–1246
in women and elderly 1246 1247
smoking cessation and 5–8 6–7 8 9 10 11 339
pulmonary (cor pulmonale) 412
pulmonary hypertension and (primary pulmonary hypertension) 290 410–411 411
rate and rhythm disturbances 366–382
rheumatic/rheumatic fever and 405–407
scleroderma and 838
signs of 313–316
spondylitic 852
surgery in patient with 414–415
symptoms of 312–313
systemic disorders and 413–414
in systemic lupus erythematosus 413 834–835
P.1804
traumatic 414
valvular 325–339 326–328
Heart failure See Congestive heart (cardiac) failure
Heart-lung transplant, for cystic fibrosis 246
Heart murmurs 315 326–327
in aortic regurgitation 326–327 335
in aortic stenosis 326–327 333
atrial myxoma causing 413
in atrial septal defect/patent foramen ovale 321
bedside maneuvers/interventions affecting 329
in cardiac failure 389
in cardiomyopathy 403
in endocarditis 1415 1416
in hypertension 426
in mitral regurgitation 326–327 330
in mitral stenosis 325–329 326–327
in mitral valve prolapse 331
in myocardial infarction 356
in patent ductus arteriosus 324
during pregnancy 416
in pulmonary stenosis 318–319
in rheumatic carditis 405
in tricuspid regurgitation 326–327 337
in tricuspid stenosis 326–327
in ventricular septal defect 322
Heart rate 314
disturbances of 366–382
normal 314
during pregnancy 416
in pulmonary embolism 282
variability in, in arrhythmia evaluation 367
Heart rhythm, disturbances of 366–382
Heart sounds 315
in atrial septal defect 321
in cardiac failure 389
in cardiomyopathy 403
in hypertension 426
in myocardial infarction 356
in pregnancy 416
in pulmonary embolism 282
in pulmonary stenosis 320
in pulmonic regurgitation 338
in tetralogy of Fallot 323
in valvular heart disease 326
Heart transplantation, for cardiac failure 396
Heart valves See Prosthetic heart valves; Valve replacement; Valvular heart disease
Heartburn (pyrosis) 536 563–564 566
Heartworm infection (dirofilariasis) 1522
Heat
disorders caused by exposure to 1592–1595
cholinergic urticaria 121 122
erythromelalgia 466
miliaria 119–120
reduction/removal of 27 1593
for heat exposure syndromes 1593 1594
Heat cramps 1593
Heat exhaustion 1593–1594
Heat rash 119–120
Heat stroke 1594–1595
Heat syncope 1593
Heat therapy, for rheumatoid arthritis 829
Heavy chain disease 798
Heavy metals See also specific type
adverse ocular effects of 179
overdose/poisoning caused by 1611
tubulointerstitial disease caused by 926 927
Hebephrenic (disorganized) schizophrenia 1056–1057
Heberden's nodes 808
Hectoral See Doxercalciferol
Heel, plantar hyperkeratosis of 129
Hegar dilators, for vaginismus 1054
Heimlich maneuver
for foreign body 214
in near drowning 1602
Heinz bodies
in glucose-6-phosphate dehydrogenase deficiency 492
unstable hemoglobins and 495
Helical (spiral) CT See Computed tomography; Spiral (helical) CT
Helicobacter pylori infection 1553
dyspepsia and 536 537
eradication therapy for 589 590
cancer incidence and 597
dyspepsia management and 537
gastric/MALT lymphoma and 599
gastritis management and 584
peptic ulcer management and 589 590
NSAID-induced ulcers and 587 590 590 591
perforation prevention and 594
rebleeding prevention and 592–593
gastric/MALT lymphoma and 584 598–599 1644
gastritis 584–585
gastric cancer and 584 597 1644
peptic ulcer disease and 584 586 588 589 590
refractory 591
resistant strains of 589
testing for 584 588 597
in dyspepsia 536
laboratory reference range for 1739
Heliotrope rash, in dermatomyositis 840
Helium-oxygen mixture (Heliox)
for asthma 237
for smoke inhalation 293
Heller cardiomyotomy, for achalasia 580
HELLP syndrome 771
Helmet cells, in microangiopathic hemolytic anemia/thrombotic thrombocytopenic purpura 497 521
Helminthic infections 1501–1535
cestodes causing 1508–1515
cholangiocarcinoma and 692 1506
eosinophilic pulmonary syndromes caused by 280 1518 1522–1523
nematodes (roundworms) causing 1515–1535
trematodes (flukes) causing 1501–1508
Helper-inducer T cells See CD4 T cells
Helvella (gyromitrin) mushroom poisoning 1629 1630
Hemangioblastoma, cerebellar 999 1000
paraneoplastic syndromes associated with 1696–1697
Hemangioma, cavernous, of liver 683
Hemarthroses, in hemophilia 526
Hematemesis
in erosive/hemorrhagic gastritis/gastropathy 582
in gastrointestinal bleeding 551 557
in Mallory-Weiss syndrome 572
in peptic ulcer disease 592
Hematin, for porphyria 1025 1704
Hematochezia
in inflammatory bowel disease 555
in lower gastrointestinal bleeding 554 555
in peptic ulcer disease 592
in rectal cancer 638
in upper gastrointestinal bleeding 551 555
Hematocrit See also specific disorder
in anemia 481
in hemolytic anemia 490 495
laboratory reference range for 1739
in polycythemia 500 500 501
in sickle cell syndromes 493
Hematogenous osteomyelitis 858 859
Hematologic disorders 481–535
anemias 481–498
cancer-related 1697 1698
chloramphenicol causing 1572
hemostasis disorders 518–531
hypercoagulable states 531–533 531
neoplastic
leukemias/myeloproliferative disorders 499–512 499 500
lymphomas 512–518
neutropenia 498–499 499
preoperative evaluation/management of patient with 36 43–44
radiation exposure and 1600
in renal failure 910
Hematoma
auricular (cauliflower ear) 181
perianal, thrombosed hemorrhoid causing 645
septal, in nasal trauma 199–200
subperichondrial 200
Hematometra, in endometrial carcinoma 738
Hematopoiesis, ineffective, in myeloplastic syndromes 504
Hematopoietic progenitor cell transplantation 802–803
Hematopoietic stimulating factors See Filgrastim; Growth factors; Sargramostim
Hematospermia 932
Hematuria 896 897 931–932 935–936
in bladder cancer 936 967
by dipstick 897 935
evaluation of 897 935–936
in focal segmental glomerular sclerosis 922
in glomerulonephritis 906
in Goodpasture's syndrome 293
hemorrhagic cystitis and 33 1683
in IgA nephropathy 917
in polycystic kidney disease 928
in renal cell carcinoma 936 969 970
in schistosomiasis 1502 1503
synpharyngitic 917
in ureteral and renal pelvis cancer 936 969
in urinary stone disease 936 944
Hemianopia See also Visual field defects
stroke causing 993
Hemiplegia See also Paralysis
stroke causing 991 993 995 996
Hemobilia 552
Hemoccult See Fecal occult blood testing
Hemochromatosis 676–677
cirrhosis and 669–670 676 677
genetic/prenatal testing for 677
hepatocellular carcinoma and 682
hyperpigmentation in 1100
hypopituitarism caused by 1105
nonalcoholic fatty liver disease and 667
Hemoclips, for bleeding peptic ulcer 593
Hemodialysis 912
for hyperkalemia 876 877
P.1805
in older adult 930
pigmentation abnormalities associated with 1100
for poisoning/drug overdose 1613 1613
with lithium 1077 1613
with methanol or ethylene glycol 1613 1628
with salicylates 1613 1634
with theophylline 1613 1637
with valproic acid 1613 1619
for renal failure 912
coagulopathy and 910
Hemodynamic status
in COPD 239
gastrointestinal bleeding and 552
in myocardial failure 386
in myocardial infarction 357 357
Hemoglobin
acute tubular necrosis/renal failure and 903–904
in anemia 481
glycated/glycosylated See Hemoglobin A1/A1a/A1b/A1c
laboratory reference range for 1739
postoperative complications and 43
unstable 495
Hemoglobin A 484
in beta thalassemia syndromes 484–485 485
in sickle cell syndromes 494 494
Hemoglobin A1/A1a/A1b/A1c (glycated/glycosylated hemoglobin)
in diabetes mellitus 1199–1200 1202 1203 1204 1205 1218 1220
pregnancy and 777
laboratory reference range for 1739
Hemoglobin A2 484
in beta thalassemia syndromes 484–485 485
laboratory reference range for 1739
in sickle cell syndromes 494
Hemoglobin AS genotype (sickle cell trait) 494 494
Hemoglobin C disorders 494–495
pregnancy and 775
Hemoglobin electrophoresis
laboratory reference range for 1739
in sickle cell syndromes 493–494 494
Hemoglobin F (fetal hemoglobin) 484
in beta thalassemia syndromes 484–485 485
laboratory reference range for 1739
in sickle cell syndromes 494 494
Hemoglobin H/hemoglobin H disease 484 484 485 485–486 486
Hemoglobin S 493 494 494
Hemoglobin saturation See SaO2
Hemoglobin SC disease 495
proliferative retinopathy in 168
Hemoglobinemia, in hemolytic anemia 490
Hemoglobinuria 897 935
in hemolytic anemia 490
iron deficiency and 482
in malaria 1497
paroxysmal nocturnal 491–492
Hemojuvelin, in juvenile-onset hemochromatosis 676
Hemolytic anemias/hemolysis 490 491
acute tubular necrosis and 903–904
autoimmune 495–496
in cold agglutinin disease 496
in glucose-6-phosphate dehydrogenase deficiency 492
in hemoglobin C disorders 494–495
in hemoglobin H disease 485
in hereditary spherocytosis 490 491
in hypophosphatemia 881 882
microangiopathic 490 497 521
in disseminated intravascular coagulation (DIC) 530
hemolytic-uremic syndrome and 522
thrombotic thrombocytopenic purpura and 497 521 521
in paroxysmal nocturnal hemoglobinuria 491
in sickle cell syndromes 493
in thrombotic thrombocytopenic purpura 521
unstable hemoglobins and 495
Hemolytic crises, in sickle cell disease 493
Hemolytic disease of newborn, prevention of 783
Hemolytic streptococcus See specific type under Group
Hemolytic transfusion reactions 533–534
acute tubular necrosis and 904
Hemolytic-uremic syndrome 522–523
E coli O157:H7 causing 522 1300 1427
Hemopericardium 414
Hemophilia A 525 526–527
Hemophilia B 528
Hemoptysis 220
in bronchiectasis 244
in Goodpasture's syndrome 293
in lung cancer 220 267
in pulmonary embolism 282
in tuberculosis 257
Hemorrhage See specific type or structure affected and Bleeding
Hemorrhagic conjunctivitis, acute, enterovirus 70 causing 1390
Hemorrhagic cystitis 33
adenovirus causing 1386–1387
chemotherapy-induced 1683
mesna for 1677 1683
Hemorrhagic fevers 1371 1376–1377
dengue 1377
Hemorrhagic (erosive) gastritis See Gastritis
Hemorrhagic pleural effusion 300
malignant 1693
Hemorrhagic pneumonia, in leptospirosis 1456
Hemorrhagic shock See Hypovolemic shock
Hemorrhoidectomy 644–645
Hemorrhoids 643–645
bleeding and 555
pruritus ani caused by 133 134
thrombosed 645
Hemosiderin 481
accumulation of See also Hemochromatosis
urine
laboratory reference range for 1739
in paroxysmal nocturnal hemoglobinuria 491
Hemosiderosis
idiopathic pulmonary 293
transfusional, in thalassemia 485 486
Hemostasis, disorders of 518–531
Hemosuccus pancreaticus 552
Hemothorax 300 302–303
Hemotympanum 184 187
Henderson-Hasselbalch equation 885
Henoch-Sch nlein (anaphylactoid) purpura 850 917–918 917
Hep A See Hepatitis A vaccine
Hep B See Hepatitis B vaccine
Hepacare See Hepatitis B vaccine
Hepar lobatum, in syphilis 1450
Heparin/low-molecular weight heparin
for acute coronary syndromes 352 353
for arterial embolism 461
for deep venous thrombosis/pulmonary embolism
in prevention 284 286 287 471
in treatment 284–289 288 472
for disseminated intravascular coagulation 531
in meningococcal meningitis 1422
for hypercoagulability 532
hyperkalemia and 876
for myocardial infarction 352 353
thrombolytic therapy and 359
for stroke 993 994
thrombocytopenia caused by 520
for transient ischemic attacks 990
Heparin-induced thrombocytopenia 520
Hepatic abscess
amebic 1468–1472 1471
pyogenic 680–681
Hepatic adenoma 683–684
oral contraceptive use and 683 753
Hepatic artery aneurysm 450
Hepatic biopsy See Liver, biopsy of
Hepatic coagulopathy 528–529
in cirrhosis 671
Hepatic cysts, hydatid 1513 1514 1515
Hepatic disease See Liver, disorders of
Hepatic encephalopathy 672
bleeding esophageal varices and 575 672
in cirrhosis 669 672
in hepatic failure 658 659
protein-restricted diet for 672 1279
Hepatic (liver) failure 658–659
acetaminophen causing 658 659 666 1616
acute 658–659
in amatoxin-type mushroom poisoning 1629 1630
antimicrobial dosage adjustment and 1558–1559
Hepatic fibrosis
drugs/toxins causing 666
in fatty liver disease 668
Hepatic hydrothorax 671
Hepatic steatosis See Fatty liver
Hepatic vein obstruction (Budd-Chiari syndrome) 678–680
Hepatitis
alcoholic 663–665
autoimmune 662–663
drugs/toxins causing 666
erythromycin causing 1569
postoperative complications associated with 43
radiation exposure and 1600
viral 652–658
chronic 657–658 659–662
postoperative complications associated with 43
cirrhosis and 654 657 659–660 669
coxsackieviruses causing 1390
in drug users 653 654 655 1298
hepatic failure and 658 659
in HIV infection/AIDS 655 660 1326
liver cancer and 653 657–658 659 681 682 683 1644
in liver transplant patients, adenoviruses causing 1387
non-ABCDE 652
transfusion-associated 534 652 653 654–655
type A 652–653 652
prevention of/immunization against 656–657 1305–1306 1307–1309 1312
for travelers 656 1312 1314
P.1806
type B 653–654 653 654
acupuncture in transmission of 1724
arthritis in 858
cancer associated with 653 659 682 683 1644
chronic 653 654 654 657 659–660 660–661
cirrhosis and 653 659–660 669
delta agent (hepatitis D) and 654 660
HIV infection/AIDS and 660 1326
maternal carrier state/transmission to newborn and 653 764
vaccination recommendations and 657 764 1311
polyarteritis nodosa and 845
prevention of/immunization against 657 1305–1306 1307–1309 1311
for travelers 1313–1314
transfusion in transmission of/screening blood for 534 653
type C 654–655 655
acupuncture in transmission of 1724
arthritis in 858
cancer associated with 681 682 683 1644
prevention of 1649
chronic 657 660 661–662
cirrhosis and 660 669
cryoglobulinemia in 655 850 924
HIV infection/AIDS and 655 660 1326
maternal carrier state/transmission to newborn and 655 764
renal disease and 924
thyroiditis and 1131 1144
transfusion in transmission of/screening blood for 654–655
type D 654
chronic 660 662
hepatitis B and 654 660
type E 655
in pregnancy 655 657
type G 655
Hepatitis A and B vaccine 657 1312
Hepatitis A immune globulin 656
during pregnancy 767
Hepatitis A vaccine 656–657 1305–1306 1307–1309 1312
in HIV infection/AIDS 1308
during pregnancy 767 1308
for travelers 656 1312 1314
Hepatitis A virus 652–653 652
Hepatitis B core antigen (HBcAg) 653
antibody to (anti-HBc) 653 654 654 659
screening blood for 534
Hepatitis B e antigen (HBeAg) 653 654 654 659
antibody to (anti-HBe) 653 654 654 659
Hepatitis B immune globulin 657
for infants born to HBsAg-positive mothers 657 1311
Hepatitis B surface antigen (HBsAg) 653 653 654
antibody to (anti-HBs) 653 653 654
in hepatocellular carcinoma 682
maternal carrier state/transmission to newborn and 653
vaccination recommendations and 657 764 1311
screening blood for 534
Hepatitis B vaccine 657 1305–1306 1307–1309 1311
in cancer prevention 657 683 1649
in HIV infection/AIDS 4 1308 1332
for newborn/pregnant patient 657 764 1308 1311
after rape/sexual assault 760 1297
for travelers 1313–1314
Hepatitis B virus 653
Hepatitis B virus DNA 653 654 659
Hepatitis C virus 654
screening blood for 534 654
Hepatitis C virus RNA 655 655 660
Hepatitis D virus (delta agent) 654
Hepatitis D virus RNA 654
Hepatitis E virus (HEV) 652 655
Hepatitis G virus (HGV) 652 655
Hepatoblastomas, in familial adenomatous polyposis 635
Hepatocellular carcinoma 681–683
cirrhosis and 657 670 681–682
hepatitis and 653 657–658 659 681 682 683 1644
paraneoplastic syndromes associated with 1696–1697
polyprenoic acid in prevention of 1649
Hepatocellular disease See also Cirrhosis; Liver, disorders of
jaundice in 649 650
Hepatocyte nuclear factor 1a, hepatic adenomas and 684
Hepatojugular reflux 314 389
Hepatolenticular degeneration See Wilson's disease
Hepatomas, polyprenoic acid in prevention of 1649
Hepatomegaly
in cardiac failure 389
in cirrhosis 669
in hairy cell leukemia 511
in myelofibrosis 503
Hepatopathy, ischemic 680
Hepatopulmonary syndrome 673
Hepatorenal syndrome 671–672
Hepatosplenic/hepatic candidiasis 1537
Hepatotoxicity 665–666
of acetaminophen 658 659 666 1616 1616
antimicrobial dosage adjustment and 1558–1559
of erythromycin 1569
of herbal supplements 1711
kava 1717
of methotrexate 831
of tetracycline 1571
of thiazolidinediones 1210
Hepcidin, in juvenile-onset hemochromatosis 676
HER-1 receptor, drugs blocking, in cancer treatment 1699
HER-2/neu oncogene
dendritic cells loaded with, in cancer treatment 1700
drugs blocking 1699
overexpression of
in breast cancer 717 719 720 720 1641 1643–1644
trastuzumab treatment and 722 1643–1644 1667 1679 1698
cancer vaccine development and 1700
in prostate cancer 1644
Herald patch, in pityriasis rosea 99
“Herbal ecstasy” (ephedrine) 1618 1711
Herbal medicines 1709 1710–1719 1711 1712–1713
advice to patients using 1711
in cancer therapy 1702
epidemiology of use of 1710
hepatic failure and 658
product formulations/standardization and 1710–1711
quality assurance and 1710
regulatory issues regarding 1710
safety of 1711
Herbicide poisoning See Pesticide poisoning
Herceptin See Trastuzumab
Hereditary angioedema 122
Hereditary hearing loss 188–189
Hereditary motor and sensory neuropathy (HMSN), types I to IV 1024
Hereditary nonpolyposis colorectal cancer (HNPCC) 636–637 1643
Hereditary polymorphous light eruption 140
Hereditary spherocytosis 490–491
Hernias
hiatal, gastroesophageal reflux and 565
surgery for, antibiotic prophylaxis for 47
vaginal (genital prolapse) 741
Herniated nucleus pulposus See Nucleus pulposus, herniation of
Herniation syndromes, space-occupying tumors causing 1001 1002
Heroin 1086 1087
acupuncture for cessation of use of 1729
overdose/toxicity of 1631
Herpangina 1389
herpetic stomatitis differentiated from 204
Herpes genitalis 108–109 1350
during pregnancy/neonatal infection 778–779 1351 1353
Herpes (pemphigoid) gestationis 127
Herpes labialis 1350
Herpes simplex infection 108–109 1350–1354
acyclovir prophylaxis/treatment and 108–109 1290 1336 1351 1352 1353 1586–1587
anorectal involvement and 645
Bell's palsy and 1030 1351 1354
decubitus ulcers and 141
disseminated/generalized 1351 1354
dermatitis in (eczema herpeticum) 96 108 1351 1355
encephalitis 1351 1354
erythema multiforme associated with 122 1351 1354
esophagitis in 571 1351 1354
gladiatorum 108
in HIV infection/AIDS 1327 1336 1350 1353
esophageal 571 1351 1354
keratitis 158 1351 1353
during pregnancy/neonatal infection 778–779 1351 1353
stomatitis/gingivostomatitis in 108 204
treatment/prevention of 1351–1354
type 1 108 1350–1354
type 2 108 1350–1354
Herpes zoster (shingles) 109–110 1354–1358
eye involvement and 110
facial paralysis in (Ramsay Hunt syndrome) 194 1356
in HIV infection/AIDS/immunocompromised host 1327 1336 1356 1357
neuralgia after 110 979 1357 1358
during pregnancy 780–781
Herpes zoster ophthalmicus 110 159
Herpesviruses 1350–1362
Herpetic stomatitis/gingivostomatitis 108 204
P.1807
Herpetic whitlow 108 1350
Herplex See Idoxuridine
Hesitancy, urinary 932
HESX1 gene mutation, in pituitary hormone deficiency 1104
Heterophil antibody tests, in mononucleosis 1359
Heterotopic pregnancy 770
HEV See Hepatitis E virus
Hexosaminidase deficiency, in juvenile spinal muscular atrophy 1022
HFE gene
in alcoholic liver disease 664
in cirrhosis 670
in hemochromatosis 676
in nonalcoholic fatty liver disease 667
hGH See Human growth hormone
HGV See Hepatitis G virus
HHV See Human herpesviruses
5-HIAA See 5-Hydroxyindoleacetic acid
Hiatal hernia, gastroesophageal reflux and 565
Hib vaccine 1305–1306
in HIV infection/AIDS 4
Hibernation, myocardial 342–343
Hiccups 540–541
HIDA scan, in cholecystitis 686
Hidradenitis suppurativa 138
HIFU See High-intensity focused ultrasound
High-altitude bronchitis 1605
High-altitude encephalopathy 1605
High-altitude pulmonary edema 1604–1605
High-altitude retinopathy 1605
High blood pressure See Hypertension
High-calcium diet 1279
High-carbohydrate diet, in porphyria 1025 1703–1704
High-density lipoproteins 1240
atherogenesis/coronary heart disease and 339 340 1240–1241 1241–1242
in diabetes mellitus 1201
diet affecting 1247–1248
estrogen replacement affecting 1187
laboratory reference range for 1739
pioglitazone affecting levels of 1210
raising levels of 8–10 341 1242 1247
fibric acid derivatives for 1250
niacin for 1249 1273–1274
rosiglitazone affecting levels of 1210
screening tests for levels of 1244–1247 1245–1246
High dose chemotherapy, with bone marrow/hematopoietic progenitor cell (stem cell) transplantation 802–803 1661 1680
High-fiber diet See Fiber, dietary
High-intensity focused ultrasound (HIFU), for benign prostatic hyperplasia 961
High-output heart failure 386
High-potassium diet 1279
High-resolution computed tomography (HRCT), in solitary pulmonary nodule 265–266
Highly active antiretroviral therapy (HAART) 1334
CMV retinitis and 1360
in cytomegalovirus disease control 570 1360 1361
gynecomastia and 1100
nephropathy progression and 923
opportunistic infection prophylaxis and 1334 1346 1347
during pregnancy 776
progressive multifocal leukoencephalopathy and 1375
varicella zoster immune restitution disease and 1357
Hilar adenopathy, in sarcoidosis 279
Hill's sign 335
Hip arthroplasty 810 864
Hip fracture, falls in elderly and 16 61
Hip protectors, fracture prevention and 16 61
Hirschsprung's disease 542
in multiple endocrine neoplasia 1192
Hirsutism 1170–1172
in persistent anovulation (polycystic ovary syndrome) 746 747 1170 1171
His-ventricular interval, long 383
Histamine
in bronchial provocation testing for asthma 224 227
drugs blocking receptors for See Antihistamines; H2 receptor blocking drugs
Histiocytosis, Langerhans cell 1104 1107
Histoplasma capsulatum (histoplasmosis) 1538–1539
bone and joint involvement in 860
in HIV infection/AIDS 1538
Histrionic (hysterical) personality disorder 1055
HIT See Heparin-induced thrombocytopenia
HIV/HIV-1 1320
blocking entry of into cells 1342
drug resistance and 1336 1339 1343 1343–1345 1344 1345
monkeypox immunization and 1388
screening blood for antibody to 534 1319 1331
serologic tests in identification of 1349
HIV-2 1320
HIV-associated cognitive/motor complex (AIDS dementia complex) 1092 1324
HIV-associated nephropathy 923
HIV infection/AIDS 1317–1348
acupuncture in transmission of 1724
adrenal insufficiency in 1327
anal cancer and 648 1329
arthritis in 857 1325
aspergillosis in 194 217 1544
autoimmunity in 1320
bacillary angiomatosis in 1328 1434
bartonellosis in 1434
biliary disease in 1326
blastomycosis in 1545
breast feeding in transmission of 776 1333
campylobacter-like organisms causing disease in 1429
cancer associated with 1328–1329 1334 1336 1644
candidiasis in
esophageal 1322 1326 1336
oral (thrush) 203 216–217 1322 1325–1326 1347
vulvovaginal 1329 1336 1347
CD4 T cells in See CD4 T cells
CDC definitions and 1317 1318
cerebral lymphoma in 1000 1003 1324 1328
cervical intraepithelial neoplasia/cervical cancer in 735 1329
Chagas' disease reactivation and 1466
cholecystitis in 1326
clinical findings in 1321–1329 1321
coccidial and microsporidial infection in 1475–1478
coccidioidomycosis in 1539
counseling and 1331 1332–1333
postexposure prophylaxis and 1333
cryptococcosis/cryptococcal meningitis in 1003 1324 1335 1543
prevention of 1347 1543
cryptosporidiosis in 1326–1327 1476–1477
cytomegalovirus infections in 168 546 570–571 1323 1325 1335 1360–1361
esophagitis 570–571 1360
prophylaxis of 1347
retinitis 168 1325 1360 1361
dementia associated with 1092 1324
diarrhea/enterocolitis in 545 546 549 1326–1327 1475–1478
differential diagnosis of 1330–1331
drug use and 1298 1319 1331
postexposure prophylaxis and 1333
endocrinologic manifestations of 1327
Epstein-Barr virus infection in 1359
esophagitis in 570–571 1322 1326
etiology of 1320
fever/FUO and 27 1286 1287 1321
folliculitis and 119 1327
gastrointestinal manifestations of 1326–1327
gastropathy in 1327
gynecologic manifestations of 1329
gynecomastia in 1100
hairy leukoplakia in 216 217 1325
health care maintenance for patients with 1331–1333 1332
hemophilia and 526
hepatic disease/hepatitis in 655 660 1326
herpes simplex infection in 1327 1336 1350 1353
acyclovir prophylaxis and 1351
esophagitis 571 1351 1354
herpes zoster and 1327 1336 1356 1357
histoplasmosis in 1538
Hodgkin's disease in 1328–1329 1644
hyperkalemia in 876
hyponatremia in 870–871
immunization recommendations in 4 1308
immunodeficiency state of 1320
incidence/prevalence of 1319
infections in 1289
Opportunistic infections
CD4 T cell levels and 1321 1321
prevention of 1331–1333 1332 1346–1347 1346
treatment of 1334 1335–1336
inflammatory reactions in 1329
influenza vaccination and 4 1308 1310 1384
intracranial mass lesions in 1003
Kaposi's sarcoma in 132 216 217 1320 1323 1328 1336 1644
laboratory findings in 1329–1330 1330
lactic acidosis and 887
leishmaniasis coinfection and 1481
lymphadenopathy in 215 217
auditory tube dysfunction/serous otitis media and 194
lymphoma in 216 1000 1003 1323 1328 1335 1644
MAC infections in 1335 1437
prevention of 1347 1437
malabsorption in 1327
measles in 1363
vaccination against 4 1304 1308 1332 1364
mental status changes in See HIV-associated cognitive/motor complex
MMR vaccination and 4 1304 1306 1308
molluscum contagiosum in 129 1327 1388
P.1808
myelopathies in 1324
myocarditis in 399
myopathy in 1325
neck findings in 217
nephropathy in 923
neurologic manifestations of 1320 1324–1325
neuropathy 1026 1325
ocular manifestations of 168
oral lesions in 216–217 1325–1326
otolaryngologic manifestations of 216–217
otologic manifestations of 194
paranasal sinuses in 217 1323–1324
pathogenesis of 1320
pathophysiology of 1320
Penicillium marneffei infection in 1546
perinatal transmission of 1319 1333
breast feeding and 776 1333
pharyngeal lesions in 216–217
pneumonia in 256 1322–1323 1334 1541 1542
CD4 T cell count and 1321 1321 1323 1346 1541
DLCO (diffusing capacity for carbon monoxide) in 223 1323
immunization against See Pneumococcal vaccine
pneumonitis in, nonspecific interstitial 1323
poliomyelitis vaccine in 4
in pregnancy 776 1333
prevention of 4 1331–1334 1332
condoms for 4 1331
postexposure prophylaxis and 1333
prognosis of 1347–1348
progressive multifocal leukoencephalopathy in 1324–1325 1375
psoriasis in 857 1328
pulmonary manifestations of 256 1322–1323
DLCO (diffusing capacity for carbon monoxide) and 223
reactive arthritis/Reiter's syndrome and 855 857
retinitis in 168 1325
rheumatic manifestations of 857 1325
rubella vaccination and 4 1306 1308
scabies in 134 135
sclerosing cholangitis in 691 1326
screening for See HIV testing
seizures in 980
sinusitis in 217 1323–1325
skin disorders in 1327–1328
sporotrichosis in 1546
staging, oral lesions in 216
strongyloidiasis in 1529
sulfonamide side effects and 1576
suppurative thyroiditis in 1145
syndrome of inappropriate ADH secretion (SIADH) and 871
syphilis and 1332 1443 1446 1447 1452
syphilis tests affected by 1332 1452
systemic complaints associated with 1321–1322
T cells in See CD4 T cells
toxoplasmosis in 1003 1324 1335 1499 1499–1500 1500
prophylaxis of 1333 1347 1500
transient ischemic attacks and 989
transmission of 1318–1320
acupuncture and 1724
blood screening/blood treatment and 534 1319 1331
to fetus/newborn 776 1333
health care providers and 1319 1333
prevention of 4 1331–1334
condoms for 4 1331
postexposure prophylaxis for 1333
rape/sexual assault and 759 1297 1298
risk/risk assessment of 1318–1319
transfusions and 534 1319 1331
treatment of 1334–1347
antiretroviral therapy 1334–1345 1337–1338 1343 1344 1345
hematopoietic stimulating factors 1346
opportunistic infections/malignancies and 1334 1335–1336
during pregnancy 776 1333
tuberculosis and 259 261
tuberculin skin test in 259 259 1323 1331–1332
tuberculosis in 257 258
chemoprophylaxis/prevention and 263 1332 1347
intestinal involvement in 614
peritoneal involvement and 562
treatment of 261
uveitis in 162
vaccine development and 1331
varicella zoster virus infection and 1327 1336 1356 1357
VDRL test in 1332
venereal warts in 645 646
weight loss in 1321–1322
Wernicke's encephalopathy in 1017
in women 1319
HIV testing 1329–1330 1329
in blood screening 534 1319 1331
after needle-stick 1319 1333
pre- and posttest counseling and 1331
in pregnancy 766
in prenatal care 764
after rape/sexual assault 759 1297
in syphilis patients 1332 1446 1447
HIV viral load tests 1330 1330
antiretroviral therapy initiation/monitoring and 1336 1339
laboratory reference range for 1739
Hives See Urticaria
Hivid See Zalcitabine
HJV gene, in juvenile-onset hemochromatosis 676
HLA See Human leukocyte antigens
HLA typing See Human leukocyte antigens (HLA), typing
HM See Hand movements
hMG See Human menopausal gonadotropins
HMG-CoA reductase inhibitors See Statin drugs
hMLH1 gene, in hereditary nonpolyposis colorectal cancer 636
HMS See Medrysone
hMSH2/hMSH6 genes, in hereditary nonpolyposis colorectal cancer 636
HMSN See Hereditary motor and sensory neuropathy
HNPCC See Hereditary nonpolyposis colorectal cancer
Hoarseness 209
benign laryngeal tumors causing 210
contact ulcers causing 210
gastroesophageal reflux and 210 566
laryngeal leukoplakia causing 210
laryngeal papillomas causing 209
laryngitis causing 210
in squamous cell carcinoma of larynx 211
vocal cord nodules and 210
vocal cord paralysis causing 213
Hodgkin's disease 514–515 1663
Epstein-Barr virus in 1360
fever caused by 1287
in HIV infection/AIDS 1328–1329 1644
secondary malignancies and 1645
Hog 1088
Holiday heart 375
Hollenhorst plaques 456
Holosystolic murmurs 315
Holter monitoring See Ambulatory electrocardiographic monitoring
Homans' sign, in deep venous thrombosis/pulmonary embolism 282 471
Home environment, of elderly patients, falls and 60 61
Home oxygen therapy 240–242 240
Homeopathy 1729–1732 1731
Homeostenosis See also Age/aging
Homocysteine
elevated serum levels of, in coronary heart disease/occlusive arterial disease 10–11 341 1706–1707
laboratory reference range for 1739
Homocystinuria 1706
Homogentisic acid oxidase, deficiency of in alkaptonuria 1704
Homonymous field defects 150
stroke causing 991 993
“Honeycomb lung,” in interstitial (diffuse parenchymal) lung disease 275
Hookworm disease 1524–1526
cutaneous larva migrans 1519
eosinophilic pulmonary syndromes and 280
Hordeolum 154
Horizontal diplopia 152
Hormone receptor sites, in breast cancer 716–717
in male 727
prognosis and 720 724
treatment and 716–717 719 720 721–722 1670 1679
Hormone replacement therapy (HRT) See Estrogen (hormone) replacement therapy
Hormone therapy
adverse ocular effects of 178
for breast cancer 712 719 721–723 1670
hormone receptor sites and 716–717 719 720 721–722 1670 1679
in male 727
breast feeding and 786
for cancer prevention 1648–1649
for cancer treatment 1670–1671
for dysfunctional uterine bleeding 729
for erectile dysfunction 951
for female infertility 749
for hypopituitarism 1106–1107
for male infertility 954
for prostate cancer 966 966 1670–1671
Hormones, ectopic production of
by islet cell tumors 1178
in paraneoplastic syndromes 1695 1696–1697
Horner's syndrome (oculosympathetic paralysis) 152
in carotid dissection 458
in cluster headache 977
in coma or stupor 1017
in lung cancer 267
ptosis in 153
stroke causing 993
P.1809
Hospice care 71
Hospital-acquired pneumonia 253–255
Hospitalization
for alcohol use/abuse/withdrawal 1085 1086
for asthma exacerbation 236
for COPD 242
for depression 1068
for diarrhea 546
for head injury 1019
infections acquired during See Nosocomial infections
for opioid overdose/withdrawal 1087
for pelvic inflammatory disease 742
for pneumonia 252
for preeclampsia/eclampsia 772
for psychiatric disorders 1041
psychiatric problems associated with 1095–1097
for schizophrenia/psychotic disorders 1058–1059
for suicidal patient 1067–1068
for third-trimester bleeding 774
for tuberculosis 260
Host defenses, impairment of See Immunocompromised host
Hot environments, disorders caused by exposure to 1592–1595
Hot flushes
estrogen replacement therapy for 1187
in menopause 760 1185
Hot tub folliculitis 118 119
House dust, avoidance therapy for allergies caused by 788–789
Household cleaning agents, poisoning caused by See Caustic/corrosive agents
Howell-Jolly bodies, in sickle cell anemia 493
HPC See Hematopoietic progenitor cell transplantation
HPMPC See Cidofovir
hPMS1/hPMS2 genes, in hereditary nonpolyposis colorectal cancer 636
4-HPR (fenretinide), in cancer prevention 1649–1650
HPV See Human papillomavirus
HRCT See High-resolution computed tomography
HRT (hormone replacement therapy) See Estrogen (hormone) replacement therapy
HSV-1 See Herpes simplex infection, type 1
HSV-2 See Herpes simplex infection, type 2
5-HT3 receptor antagonists, for chemotherapy-related nausea and vomiting 1682
HTLV See Human T cell lymphotropic/leukemia virus
Humalog See Insulin lispro
Human bite wounds 1296–1297
Human chorionic gonadotropin (hCG)
in amenorrhea, pregnancy and 1183 1184
in ectopic pregnancy 763 770
in gestational trophoblastic disease 774
hyperthyroidism and 774
gynecomastia and 1100
hyperthyroidism during pregnancy and 774 1136 1142
laboratory reference range for 1737
for male infertility 954 1107
pregnancy tests and 763
spontaneous abortion and 768
testicular tumors producing 972 1182 1183
Human diploid cell (HDCV) rabies vaccine 1314 1370–1371
Human granulocytic ehrlichiosis/anaplasmosis 1392 1397
Human growth hormone (somatotropin) 1107
Human herpesvirus 1 and 2 See Herpes simplex infection
Human herpesvirus 3 See Varicella-zoster virus
Human herpesvirus 4 See Epstein-Barr virus
Human herpesvirus 6 1355 1362
aphthous ulcers and 204
Human herpesvirus 7 1355 1362
Human herpesvirus 8 (Kaposi's sarcoma-associated herpes virus) 132 1320 1362 1644
Human herpesviruses 1350–1362
Human IL-1 receptor antagonist See Interleukin-1 (IL-1) receptor antagonist
Human immunodeficiency virus (HIV/HIV-1/HIV-2) 1320
screening blood for antibody to 534 1319 1331
Human insulin 1212
Human interferons See also specific type under Interferon
Human leukocyte antigens (HLA) 800–802 801
disease associations of 800–802 801
typing 800
for granulocyte transfusions 535
for HPC transplant 802
for platelet transfusions 535
for renal transplant 802 913
Human menopausal gonadotropins (hMG), for ovulation induction 750
Human metapneumovirus 1381–1382
Human monocytic ehrlichiosis/anaplasmosis 1392 1396–1397
Human papillomavirus
in anal cancer 648
in cancer etiology 1644
vaccine development and 1700
cancer in HIV infection/AIDS and 1329
in cervical intraepithelial neoplasia/cancer 735 736
screening for 1655
warts caused by 127
anorectal involvement and 645–646
vaginal/vulvar involvement and 732 733
Human parvovirus B19 infection See Parvovirus B19 infection
Human T cell lymphotropic/leukemia virus (HTLV) 1320 1375–1376
myelopathy of 1016 1375–1376
transfusion in transmission of/screening blood for 534 1016 1375
Humanized anti-interleukin-2 receptor antibody 804
Humidifier lung 296
Humoral immunity See also B lymphocytes; Immunoglobulins
infections associated with defects in 1289
Humulin 1212 1213 1215
Hungry bone syndrome 1147
Huntington's disease 1010–1011 1092
genetic/prenatal testing for 1011
parkinsonism differentiated from 1008
H rthle cell thyroid carcinoma 1123 1126 1129
HUS See Hemolytic-uremic syndrome
Hyaline, alcoholic (Mallory bodies/hyalin) 667
Hyaline casts 897 935
Hybridization
comparative genomic, cancer development studied with 1641
in situ, for HER-2/neu assessment in breast cancer 717
Hydatid disease/cysts (hydatidosis) 1513–1515
alveolar (multilocular) 1513 1515
cystic (unilocular) 1513 1513–1515
Hydatidiform mole 773–774
hyperthyroidism in 774 1136
Hydralazine
for cardiac failure 394
for hypertension 437 438
during pregnancy 416
urgencies/emergencies 443 445
nutrients affected by 1260
Hydration See Fluid management/hydration
Hydrocarbon toxicity/abuse 1627 1632–1633 1632
pneumonitis and 294 1632 1633
Hydrocele 933
in filariasis 1522 1523 1524
in testicular cancer 972
Hydrocephalus
in cryptococcal meningitis 1543
intracranial aneurysm causing 996
intracranial mass lesion causing 1002
normal-pressure 1020
Hydrochlorothiazide 428 429
in combination products 430 434 435
Hydrocodone 74 78
Hydrocortisone 1192 1193
for acute adrenal insufficiency 1164
for Addison's disease 1166
for hypopituitarism 1106
topical 87
Hydro-Diuril See Hydrochlorothiazide
Hydrofluoric acid burns 1597 1617
Hydrogen breath test
in irritable bowel syndrome 615–616
in lactase deficiency 606
Hydrogen cyanide gas, poisoning caused by 1623
Hydromorphone 74 77
Hydronephrosis, in tubulointerstitial disease 926 927
Hydrophobia, in rabies 1370
Hydrops
endolymphatic See Endolymphatic hydrops
fetalis 484 485
of gallbladder 687
Hydroquinone, for hyperpigmentation 143
Hydrothorax, hepatic 671
b-Hydroxybutyrate/hydroxybutyric acid
in alcoholic ketoacidosis 888
in diabetic ketoacidosis 887 888 1229
Hydroxychloroquine
for lupus erythematosus 105 835
for malaria chemoprophylaxis/treatment 1496
for rheumatoid arthritis 832
18-Hydroxycorticosterone, in hyperaldosteronism 1173
5-Hydroxyindoleacetic acid (5-HIAA)
in carcinoid syndrome 1692
laboratory reference range for 1739
11-Hydroxylase/P450c11 deficiency 1170 1173 1183
17-Hydroxylase/P450c17 deficiency 1173 1183
P.1810
21-Hydroxylase/P450c21 deficiency 1165 1170 1171 1183
Hydroxymethylglutaryl coenzyme A (HMG-CoA) reductase inhibitors See Statin drugs
17-Hydroxyprogesterone, in amenorrhea 1183
3b-Hydroxysteroid dehydrogenase deficiency, amenorrhea in 1183
17b-Hydroxysteroid dehydrogenase-3 deficiency 1171
11b-Hydroxysteroid dehydrogenase, in licorice-induced hypokalemia 874 1173
5-Hydroxytryptamine-3 receptor antagonists, for chemotherapy-related nausea and vomiting 1682
Hydroxyurea
in cancer chemotherapy 1675
for essential thrombocytosis 502
for sickle cell disease 494
25-Hydroxyvitamin D3 See Calcifediol
Hydroxyzine 789 1045
for insomnia 1045 1080
for pruritus 91
Hygroton See Chlorthalidone
Hylorel See Guanadrel
Hymen
imperforate, amenorrhea caused by 1183
remnants of, painful intercourse caused by 747 748
Hymenolepis
diminuta (rodent tapeworm) 1508 1509
nana (dwarf tapeworm) 1508 1509
Hyoscyamine, for irritable bowel syndrome 617
Hyoscyamus niger, toxicity of 1620
Hypaque enema See Diatrizoate meglumine (Hypaque) enema
Hyperacusis 189–190
Hyperadrenergic syndrome, in mitral valve prolapse 331
Hyperaldosteronism 1172–1174
glucocorticoid-remediable 874
hypernatremia and 871
hypertension and 423 1172–1173 1173
hypokalemia and 874 874 1172 1173
saline-unresponsive metabolic alkalosis and 892
Hyperalimentation See Central vein nutritional support
Hyperandrogenism
acne and 115
amenorrhea caused by 1183 1184
in hirsutism/virilization 1170 1171
Hyperbaric oxygen therapy
for acute high-altitude encephalopathy 1605
for acute high-altitude pulmonary edema 1604
for acute mountain sickness 1604
for carbon monoxide poisoning 1611 1621
for clostridial myonecrosis (gas gangrene) 1409
for decompression/dysbaric illness 1603
Hyperbilirubinemia 649 650 651
in biliary tract carcinoma 693
in choledocholithiasis/cholangitis 689
Hypercalcemia 878–880 879
in Addison's disease 1152 1166
cancer-related 267 879 1152 1153 1690–1691 1695 1696
differential diagnosis of 1152–1153
familial hypocalciuric 874 1151 1152
hypercalciuria and 879 944 1150
hyperparathyroidism and 879 1150 1150–1151 1151
in multiple endocrine neoplasia 1191
hypertension and 424
in hyperthyroidism 1152
lithium use and 1076
mental status changes and 1103
in renal failure/dialysis patients 880 908
in sarcoidosis 279 1152
Hypercalciuria 944 944 945
hypercalcemia and 879 944 1150
in hyperparathyroidism 944 945 1150
with hypocalcemia 1147 1148
with hypomagnesemia 874
in hypoparathyroidism treatment 1149
in sarcoidosis 279
Hypercapnia See Respiratory acidosis
Hypercarotenosis 1100 1276
Hyperchloremic normal anion gap acidosis 888–890 889 891
alcoholic ketoacidosis and 888
diabetic ketoacidosis and 887–888 1231
parenteral nutritional support and 890 1284
renal disease/renal tubular acidosis and 888 926
urinary anion gap in assessment of 890
Hypercholesterolemia
clinical presentations in 1243–1244
familial 1241
heart disease risk and 339 340 1240–1241 1241–1242
management of See also Lipid-lowering therapy
in heart disease prevention 341
in nephrotic syndrome 920 921
screening for 1244–1247 1245–1246
Hyperchylomicronemia 1243–1244
familial 1241
Hypercoagulability 531–533 531
in antiphospholipid antibody syndrome 837–838
deep venous thrombosis/pulmonary embolism and 281 470
in nephrotic syndrome 921
in noncirrhotic portal hypertension 680
in paroxysmal nocturnal hemoglobinuria 491
Hypercortisolism 1167–1170
Hyperemesis gravidarum 767
Hypergammaglobulinemia
in bronchiectasis 243
chronic pancreatitis and 697
Hypergastrinemia
carcinoid tumors and 599
in pernicious anemia gastritis 585
in Zollinger-Ellison syndrome (gastrinoma) 595 596 1178
Hyperglycemia See also Diabetes mellitus
alcoholic ketoacidosis and 888
antipsychotic drug use and 1062
coma and See Hyperglycemic (diabetic) coma
control of See Glycemic control in diabetes
in diabetic ketoacidosis 887 1228–1229 1228
differential diagnosis of 1201 1201
drugs causing 1201
in hyperglycemic hyperosmolar state 1228 1231–1232
hypernatremia and 871
hypertonic hyponatremia and 867
insulin action affected by 1196
in pancreatic and periampullary carcinoma 700
in pancreatitis 1201
parenteral nutritional support and 1284
prebreakfast 1218–1219 1219
in pregnancy, congenital anomalies caused by 777
secondary causes of 1201 1201
treatment of See Antidiabetic agents, oral; Insulin therapy
Hyperglycemic (diabetic) coma 1198
in diabetic ketoacidosis 1227–1231 1228
in hyperglycemic hyperosmolar state 1228 1231–1232
lactic acidosis and 1228 1233
Hyperglycemic hyperosmolar state 1228 1231–1232
Hyperhomocysteinemia, in coronary heart disease/occlusive arterial disease 10–11 341 1706–1707
Hypericin/Hypericum perforatum (St. John's wort) 1711–1714 1713
Hyperinfection syndrome, in strongyloidiasis 1529 1530
Hyperinsulinemia
hypoglycemic
insulinoma causing 1235
islet hyperplasia causing (noninsulinoma pancreatogenous hypoglycemia syndrome) 1237
in insulin resistance syndrome (syndrome X) 1197–1198
Hyperkalemia 875–876 875 877
in acidosis 875 889
adrenocortical insufficiency/Addison's disease and 876 1163 1164
in diabetic ketoacidosis 875 1230
genetic disorders associated with 874
in HIV infection/AIDS 876
in hyperglycemic hyperosmolar state 1232
in renal failure 901 908–909
in tubulointerstitial disease 926
Hyperkalemic hyperchloremic acidosis 889
Hyperkalemic periodic paralysis 874 1037
Hyperkeratosis, plantar, of heels 129
Hyperketonemia
in diabetic ketoacidosis 887 1228 1228
at end of life 82
Hyperleukocytosis, in acute leukemia 508
Hyperlipidemia
antipsychotic drugs and 1062 1063
in diabetes mellitus 1201 1243 1244
familial combined 1241
garlic for 1714–1715
isotonic hyponatremia and 866–867
in nephrotic syndrome 920 921 1244
protease inhibitors causing 1340
treatment of See Lipid-lowering therapy
Hypermagnesemia 884
in acute tubular necrosis 904
Hypermetabolism
in burn injury 1598
in HIV infection/AIDS 1322
in pheochromocytoma 1175
Hypermethioninemia, newborn screening for, in homocystinuria diagnosis 1706
Hypernatremia 871–872
dehydration and 871
in enteral nutritional support 1283
in diabetes insipidus 871 1109 1110
in diabetes mellitus/hyperglycemia 871
Hyperopia 153
Hyperosmolality (hyperosmolar disorders) 872
in diabetic ketoacidosis 1229
hyperglycemia and (hyperglycemic hyperosmolar state) 1228 1231–1232
P.1811
Hyperosmolar nonketotic dehydration, parenteral nutritional support and 1284
Hyperostosis, ankylosing (diffuse idiopathic skeletal/DISH) 853
Hyperoxaluric calcium nephrolithiasis 946
Hyperparathyroidism 1149–1155 1150
bone pain in 1102
hypercalcemia and 879 1150 1150–1151 1151
hypercalciuria and 944 945
lithium use and 1076
in multiple endocrine neoplasia 1150 1191 1192
after parathyroidectomy 1153
parathyroidectomy for 1153
in renal failure 911
bone changes and 911 1150
Hyperpathia
intracranial mass lesions causing 1001
stroke causing 991
Hyperphosphatemia 882–883 882
in lactic acidosis 1233
parenteral nutritional support and 1284
in renal failure 882 883 901
acute tubular necrosis 904
hypocalcemia/hyperparathyroidism and 878 883 901
Hyperpigmentation 143 1100
in Addison's disease 143 1100 1165
in alkaptonuria 1704
Berloque 143
busulfan-induced 1684
drugs causing 143 148 1100
chemotherapy agents and 1683
endocrine causes of 1100
nail, drugs causing 145 149 1100
in porphyria cutanea tarda 112
postinflammatory 143
Hyperprolactinemia 1113–1115 1113
amenorrhea and 1114 1184 1185
gynecomastia and 1100
hypogonadotropic hypogonadism and 1106 1113 1179
nipple discharge in 704
risperidone-induced 1060
Hyperproteinemia, isotonic hyponatremia and 866–867
Hyperreactio luteinalis 1171
Hypersensitivity, visceral
chest pain and 581
irritable bowel syndrome and 615
Hypersensitivity pneumonitis 296–297 296
Hypersensitivity reactions See also Allergies/allergic reactions
to drugs See Drug allergy
in HIV infection/AIDS 1320
in nutritional assessment 1263
in schistosomiasis 1502
testing for 1315–1316
Hypersomnias 1080
Hyperstat See Diazoxide
Hypertension 419–445
aortic dissection and 425 451
atherosclerosis and 425
atrial fibrillation and 375 375
cardiac failure and 387 424–425 440
cardiovascular disease/risk factors and 424–425 441
cerebrovascular disease and 425
classification of 419–424 420
in coarctation of aorta 319 320
complications of untreated disease and 424–425
contraceptive-related 424
in Cushing's syndrome 423 1169 1171
dementia and 425
in diabetes mellitus/diabetic nephropathy 423 425 439–440 1222
ACE inhibitors for 425 433 440 440 923 1203–1205 1205 1222
antihypertensive therapy regimens for 439 439–440 440 1203–1205 1205 1222 1225
benefits of control of 423 425 439–440 923 1204–1205 1222
in elderly 54–55
estrogen use and 424
fibromuscular dysplasia/renal artery stenosis and 423 460 464 913
in glomerulonephritis 906 915
headache and 32 425
in heart disease 314 424–425
hyperaldosteronism and 423 1172–1173 1173
intracerebral hemorrhage and 425 994
intracranial See Intracranial hypertension
intraocular See Intraocular hypertension
malignant 442
headache in 32
management of 420
in blacks 440–441
in diabetic patients 439 439–440 440 1203–1205 1222
in elderly 54–55 65
heart disease prevention and 11–12
lifestyle modifications/nonpharmacologic therapy and 419 420 421 421 426–427
pharmacologic 421 427–441 428–432 434–435 436 438 440
developing regimen for 421 437–439
follow-up and 441
general principles of 427–428
goals of 427 427
patient selection for 420 427 427
for urgencies/emergencies 442–445 443–444
preoperative 40–41
metabolic syndrome (syndrome X/CHAOS) and 422
oral contraceptive use and 424 753
in pheochromocytoma 423–424 425 1174 1176
in poisoning/drug overdose 1609
in polycystic kidney disease 928
portal See Portal hypertension
during pregnancy 416–417 424 771–773 772 779
preoperative evaluation/management of patient with 40–41
prevention of 11–12
in elderly 54–55
exercise/activity in 12 421 422 426
primary (essential) 419–422
in pregnancy 779
pulmonary See Pulmonary hypertension
renal disease caused by 425
renal disease causing 422–423
renal failure and 906 907 908 909
renal vascular 423 460
resistant 441–442 442
retinochoroidopathy in 167–168
secondary 422–424 422
stroke and 425
Hypertensive emergencies 442–445 443–444
monoamine oxidase inhibitors causing 1073
in pheochromocytoma 424 1174 1176 1177
in scleroderma 839
Hypertensive encephalopathy 425 442
Hypertensive nephropathy 425 442
Hypertensive urgencies 442–445 443–444
Hyperthecosis See Polycystic ovary syndrome
Hyperthermia 26–28 27
antipsychotic drugs causing See Neuroleptic malignant syndrome
malignant 1610
in poisoning/drug overdose 1610
monoamine oxidase inhibitor interactions and 1610 1629
regional
as adjunct to radiation therapy 1660
for benign prostatic hyperplasia 961
Hyperthyroidism (thyrotoxicosis) 1135–1143
amiodarone-induced 1136 1137
apathetic 1138 1142
atrial fibrillation in 375 1137 1138 1141–1142
cancer-related 1136 1696
cardiac disorders/failure and 389 1137 1141–1142
complications of 1138
treatment of 1141–1143
differential diagnosis of 1138
eye disease associated with (dysthyroid eye disease) 170 1135 1137 1140 1141
factitious 1135 1138
functioning thyroid carcinoma causing 1124
in gestational trophoblastic disease 774
goiter and 1130 1131 1137 1140–1141
Hashimoto's thyroiditis causing 1136 1141 1144 1146
hypercalcemia in 1152
hyperphagia/weight gain in 1099
iodine-induced (jodbasedow disease) 1135
lipid abnormalities and 1244
mental changes associated with 1103
after parathyroidectomy 1153
periodic paralysis and 1137 1138 1142–1143
pituitary tumor/hyperplasia causing 1135–1136 1138
postpartum 1136 1144
during pregnancy 781 1136 1142
struma ovarii causing 1135 1142
subacute thyroiditis causing 1135 1141 1144
subclinical 1138 1142
thyroid function tests in 1116 1117 1137–1138
toxic adenoma/solitary nodule causing 1135 1140
TSH levels in 1116 1117
weight loss in 1137
Hyperthyroxinemia 1106
Hypertonic hyponatremia 866–867 867
Hypertonic saline, for hyponatremia 870
Hypertrichosis, in porphyria cutanea tarda 112
Hypertriglyceridemia 1244 1252
alcohol use/abuse and 1243 1244 1252
in atherogenesis/coronary heart disease 341 1241–1242 1252
in diabetes mellitus 1201 1243 1244
estrogen replacement therapy and 1188
P.1812
in nephrotic syndrome 920 921
nonalcoholic fatty liver disease and 667
pancreatitis and 695 1252
screening for 1244–1247
Hypertrophic cardiomyopathy See Cardiomyopathy
Hypertrophic gastropathy (M n trier's disease) 585
Hypertrophic pulmonary osteoarthropathy 222 862–863
rheumatoid arthritis differentiated from 829
Hypertrophic subaortic stenosis, idiopathic (IHSS) 402
Hyperuricemia 810 811 811 812
cancer-related/chemotherapy-induced 1691–1692
allopurinol for 1677 1691 1692
in gout 810 811 812
renal failure and 904 908
in transplant patient 814
urinary stone formation and 811 930 946
Hyperuricosuric calcium nephrolithiasis 945–946
Hyperventilation 305
lactic acidosis and 1233
in metabolic acidosis 890
in near drowning victim 1603
neurogenic, in coma or stupor 305 1018
respiratory alkalosis and 893 894
voluntary, for acute mountain sickness 1604
Hyperviscosity syndrome
in myeloma 515
in Waldenstr m's macroglobulinemia 517 518
Hypervitaminosis A 1276
Hypervolemic hypernatremia 872
Hypervolemic hypotonic hyponatremia 867 870
Hyphema 171
Hypnagogic hallucinations, in narcolepsy 1080
Hypnosis/hypnotherapy
for chronic pain disorders 1050–1051
for conversion disorders 1049
Hypoadrenalism See Adrenocortical insufficiency
Hypoalbuminemia
ascites and 559
in hookworm disease 1525
hypocalcemia and 877
in protein-losing enteropathy 614
Hypoaldosteronism 1165
in renal tubular acidosis 889 889 1165
Hypocalcemia 877–878 878
in acute tubular necrosis 904
familial 874
with hypercalciuria 1147 1148
hypoparathyroidism and 877 878 1147 1148 1149
magnesium disturbances and 878 883
mental status changes and 1103
muscle cramps caused by 878 1102
in pancreatitis 694–695 696 878
after parathyroidectomy 1153
in pseudohypoparathyroidism 1147
renal failure and 878 901
tetany and 878 1147 1148
Hypocalciuria 879
Hypocalciuric hypercalcemia 879
familial 874 1151 1152
Hypocapnia See Respiratory alkalosis
Hypochloremia, in respiratory acidosis 893
Hypochlorite, for skin decontamination 1611 1632
Hypocholesterolemic drugs See Lipid-lowering therapy
Hypochondriasis 1048
panic disorder and 1043
Hypocitraturic calcium nephrolithiasis 946
Hypocomplementemia, in lupus erythematosus 105 835
Hypofibrinogenemia, in disseminated intravascular coagulation 530
Hypogammaglobulinemia
in chronic lymphocytic leukemia 510
common variable immunodeficiency causing 796
infections associated with 1289
Hypoglycemia 1220 1233–1239
adrenocortical insufficiency/Addison's disease and 1165
alcoholic ketoacidosis and 888
alcohol-related 1234 1234 1238
alimentary 1234 1234 1238
altered awareness of 1220
in insulinoma 1235
cancer-related 1696
coma/mental status changes caused by 1103 1228
in poisoning/drug overdose 1608
exercise-induced 1217
extrapancreatic tumors causing 1237
factitious 1234 1238–1239
fasting 1233–1234 1234 1234
after ethanol ingestion 1238
in insulinoma diagnosis 1235
functional 1238
glucagon response to, lack of in type 1 diabetes 1220
immunopathologic 1234 1234 1239
insulin-induced 1202 1204 1220
late (occult diabetes) 1234 1238
in malaria (severe P falciparum infection) 1497
pancreatic B cell tumors/insulinoma causing 1178 1234–1237 1234
pentamidine-induced 1239 1542
persistent islet hyperplasia causing (noninsulinoma pancreatogenous hypoglycemic syndrome) 1237
postgastrectomy 1238
postprandial (reactive) 1234 1234 1238
after ethanol ingestion 1238
Hypoglycemic agents See Antidiabetic agents; Insulin therapy
Hypoglycemic unawareness 1220
in insulinoma 1235
Hypogonadism 1104–1105
female 1104 1105 1183 1184 1185–1189
amenorrhea in 1183 1184
premature (premature ovarian failure) 1184–1185
in Turner's syndrome 1183 1184 1189
growth hormone-secreting pituitary tumor causing 1111
in HIV infection/AIDS 1327
hypergonadotropic 1179–1180 1180 1181
in hyperprolactinemia 1106 1114
hypogonadotropic 953 954 1104 1104–1105 1105–1106 1106–1107 1179 1180 1181
male 1104 1105 1179–1182 1180
gynecomastia and 1100
infertility and 953 953 954
sexual dysfunction and 951 1101
mental changes associated with 1103
Hypokalemia 873–875 873
in diabetic ketoacidosis 1230
genetic disorders associated with 874 874
in heat stroke 1595
hyperaldosteronism and 874 874 1172 1173
hypomagnesemia and 883
metabolic alkalosis and 891 892
parenteral nutritional support and 1284
in renal failure 908
renal tubular acidosis and 889 889
Hypokalemic hyperchloremic metabolic acidosis 889
Hypokalemic periodic paralysis 874 1037
in hyperthyroidism 1137 1138 1142–1143
Hypomagnesemia 883–884 883
hypocalcemia/hypoparathyroidism and 878 883 1147
parenteral nutritional support and 1284
Hypomagnesemia-hypercalciuria syndrome 874
Hypomania 1075
in cyclothymic disorders 1067
Hyponatremia 866–871 867
adrenocortical insufficiency/Addison's disease and 869 1163 1164
encephalopathy and 870
endurance exercise causing 869
in HIV infection/AIDS 870–871
in hyperglycemic hyperosmolar state 867 1232
in hypothyroidism 869 1131 1132–1133
idiosyncratic drug reactions causing 869
MDMA use/abuse and 869 1618
mental status changes caused by 1103
mineralocorticoid-responsive, in elderly 869
after pituitary surgery 1106
polydipsia causing 869 1058
in porphyria 1703
postoperative 869
in syndrome of inappropriate ADH secretion 868–869 868
Hypoparathyroidism 1147–1149 1149
hypocalcemia and 877 878 1147 1148
after parathyroid surgery 1147
Riedel's thyroiditis causing 1145
tetany and 878 1147 1148
after thyroidectomy 1125 1126 1140 1147
Hypoperfusion, end organ, in shock/impending shock 478
Hypophosphatasia, osteomalacia in 1160
Hypophosphatemia 880–882 881
in diabetic ketoacidosis 1230–1231
in hyperglycemic hyperosmolar state 1232
osteomalacia/rickets and 874 1159 1161
Hypophysectomy, for breast cancer 722
Hypopigmentation 143–144
endocrine causes of 1100
in tuberous sclerosis 1006
Hypopituitarism
amenorrhea and 1183 1184 1185
anterior 1104–1108
mental status changes and 1103
posterior 1108–1110
Hypopnea See Apnea
Hypoprothrombinemia, in cirrhosis 673
Hypopyon 153
in anterior uveitis 162
in bacterial keratitis 158
Hyporeninemic hypoaldosteronemic renal tubular acidosis 889 889 891 1165
Hypospadias 933
Hypotension 477–480
ACE inhibitors causing 391
in Addison's disease 1165
bleomycin-induced 1685
in desensitization therapy 1316
in diabetes mellitus 1198
P.1813
dysautonomia (autonomic dysfunction) and 987
myocardial infarction and 363
orthostatic (postural) See Orthostatic (postural) hypotension
after pheochromocytoma removal 1177
in poisoning/drug overdose 1608–1609
right ventricular infarction and 363–364
in shock/impending shock 478
syncope and 384
transient ischemic attacks and 989
Hypotensive agents See Antihypertensive drug therapy
Hypothalamus
disorders of 1103–1115
amenorrhea caused by 1183 1184
obesity in 1099 1106
pituitary gland regulation and 1103–1104
Hypothermia
drowning and 1602 1603
of extremities 1591
in poisoning/drug overdose 1608
rhabdomyolysis and 843
systemic (accidental) 1589–1591
Hypothyroidism 1105 1106 1131–1135
amiodarone-induced 1131 1133 1136
cardiac disorders/failure and 389 1132
cretinism and 1103
fetal, maternal hyperthyroidism and 1131 1142
fibromyalgia in 821
goiter and 1130 1131
Hashimoto's thyroiditis and 1144 1146
after hyperthyroidism treatment 1139 1140
hyponatremia in 869 1131 1132–1133
lipid abnormalities and 1243 1244
lithium causing 1076
mental status changes in 1103
postpartum 1136 1144
during pregnancy 781 1133–1134
preoperative evaluation/management of patient with 46
Riedel's thyroiditis causing 1145
Schmidt's syndrome and 1144 1165 1201
subacute (deQuervain's) thyroiditis causing 1131 1144
thyroid function tests in 1117 1117 1132
after thyroidectomy 1125 1126
TSH deficiency/levels in 1105 1106 1117 1117 1131 1132 1134
weight gain in 1099 1132
weight loss in 1132
Hypotonic hyponatremia 867–870 867
Hypoventilation
alveolar
central 305
in chronic mountain sickness (Monge's disease) 1605
primary (Ondine's curse) 304–305
obesity and (Pickwickian syndrome) 305
Hypovolemic hypernatremia 872
Hypovolemic hypotonic hyponatremia 867 868
Hypovolemic shock 477
in myocardial infarction 363
Hypoxemia
in ARDS 309 310
in asthma 228 236 237
in COPD 238 242
home oxygen therapy and 240–241 240
dyspnea and 218
in interstitial (diffuse parenchymal) lung disease 275
in malignant pleural effusion 302
in near drowning victim 1602
in respiratory failure 308
Hypoxia
air travel and 1606
chronic, in Monge's disease 1605
in heart disease 312
at high altitude 1604
lactic acidosis and 887
in near drowning victim 1602
in pulmonary embolism 281
Hysterectomy See also Menopause, surgical
antibiotic prophylaxis for 47
for cervical cancer 737
for endometrial carcinoma 739
for endometriosis 741
for ovarian cancer 746
for pelvic inflammatory disease 743
premature ovarian failure and 1185
for uterine leiomyoma 738
for uterine prolapse 741
Hysteria (somatization disorder) 1048
Hysterical conversion (conversion disorder) 1048 1049
pseudoseizures and 983 1048
Hysterical (histrionic) personality disorder 1055
Hysterosalpingography 729 749
Hysteroscopy 729
in abnormal premenopausal bleeding 728–729
Hytakerol See Dihydrotachysterol
Hytrin See Terazosin
Hyzaar See Losartan, with hydrochlorothiazide
123I
for mIBG in pheochromocytoma diagnosis 1176
for thyroid scanning 1117 1118
for whole body scanning, in thyroid cancer surveillance 1127–1128
125I-iothalamate scanning, in renal function evaluation 899
131I
for goiter 1131
for Graves' disease/hyperthyroidism 1139–1140
ophthalmopathy flares and 1140 1141
for thyroid cancer treatment 1126–1127
for thyroid scanning 1118
for whole body scanning, in thyroid cancer surveillance 1127–1128
131I mIBG, in pheochromocytoma diagnosis 1176
131I-orthoiodohippurate scanning, in renal function evaluation 899
131I Tositumomab See Tositumomab
EAN: 2147483647
Pages: 71